HEADER HYDROLASE 24-AUG-06 2I5I TITLE CRYSTAL STRUCTURE OF A PUTATIVE CELLOBIOSE-PHOSPHATE CLEAVAGE PROTEIN TITLE 2 (EF3048) FROM ENTEROCOCCUS FAECALIS V583 AT 1.70 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: UPF0249 PROTEIN EF_3048; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROCOCCUS FAECALIS; SOURCE 3 ORGANISM_TAXID: 226185; SOURCE 4 STRAIN: V583; SOURCE 5 GENE: EF3048; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS PUTATIVE CELLOBIOSE-PHOSPHATE CLEAVAGE PROTEIN, STRUCTURAL GENOMICS, KEYWDS 2 JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE KEYWDS 3 INITIATIVE, PSI-2, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 25-OCT-17 2I5I 1 REMARK REVDAT 5 18-OCT-17 2I5I 1 REMARK REVDAT 4 13-JUL-11 2I5I 1 VERSN REVDAT 3 28-JUL-10 2I5I 1 HEADER TITLE KEYWDS REVDAT 2 24-FEB-09 2I5I 1 VERSN REVDAT 1 05-SEP-06 2I5I 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF HYPOTHETICAL PROTEIN (EF3048) FROM JRNL TITL 2 ENTEROCOCCUS FAECALIS V583 AT 1.70 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELX REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.45 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : THIN SHELLS REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.146 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.144 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.185 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2883 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 59414 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.139 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.137 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.179 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 2615 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 52592 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4069 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 363 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 4426.4 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 3978.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 3 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 17818 REMARK 3 NUMBER OF RESTRAINTS : 22295 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 ANGLE DISTANCES (A) : 0.024 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.049 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.027 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.040 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.044 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.017 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.052 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. NCS RESTRAINTS WERE APPLIED BETWEEN RESIDUES 2-262 REMARK 3 OF CHAINS A AND B. REMARK 3 3. REFINEMENT WAS AGAINST INTENSITY DATA. REMARK 3 4. REFINEMENT WAS CARRIED WITH THE TWIN LAW OF [K,H,-L] WITH REMARK 3 THE TWIN FRACTION OF 0.3513. THE RFREE DECREASES FROM 0.27 TO REMARK 3 0.1888. REMARK 3 5. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION REMARK 3 DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE REMARK 3 RESIDUES WAS REDUCED TO 0.75 TO ACCOUNT FOR THE REDUCED SCATTERING REMARK 3 POWER DUE TO PARTIAL S-MET INCORPORATION. REMARK 4 REMARK 4 2I5I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-AUG-06. REMARK 100 THE DEPOSITION ID IS D_1000039162. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAY-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918370,0.978981,0.979291 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 MONOCHROMATOR (HORIZONTAL REMARK 200 FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59414 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 29.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.50500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 40.0% MPD, 0.1M HEPES PH 7.0, VAPOR REMARK 280 DIFFUSION,SITTING DROP,NANODROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 65.26500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 37.68077 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 28.58667 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 65.26500 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 37.68077 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 28.58667 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 65.26500 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 37.68077 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 28.58667 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 75.36153 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 57.17333 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 75.36153 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 57.17333 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 75.36153 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 57.17333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC REMARK 300 UNIT WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 REMARK 300 FOR INFORMATION ON GENERATING THE BIOLOGICAL REMARK 300 MOLECULE(S). REMARK 300 SIZE EXCLUSION CHROMATOGRAPHY SUPPORTS THE ASSIGNMENT REMARK 300 OF A HEXAMER AS THE BIOLOGICALLY SIGNIFICANT REMARK 300 OLIGIMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 12390 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 53790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -64.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 65.26500 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 113.04230 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 -65.26500 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 113.04230 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 379 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 397 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 408 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 2 OG REMARK 470 GLN A 93 CD OE1 NE2 REMARK 470 GLU A 98 CG CD OE1 OE2 REMARK 470 GLU A 103 CG CD OE1 OE2 REMARK 470 LYS A 138 CE NZ REMARK 470 ILE A 161 CG2 CD1 REMARK 470 GLU A 162 CG CD OE1 OE2 REMARK 470 LYS A 164 CG CD CE NZ REMARK 470 GLU A 178 CG CD OE1 OE2 REMARK 470 LYS A 186 CE NZ REMARK 470 GLU A 191 CG CD OE1 OE2 REMARK 470 GLU A 204 CG CD OE1 OE2 REMARK 470 ARG A 233 CD NE CZ NH1 NH2 REMARK 470 GLU A 249 CD OE1 OE2 REMARK 470 SER B 2 CB OG REMARK 470 LYS B 5 CD CE NZ REMARK 470 GLU B 86 CG CD OE1 OE2 REMARK 470 LYS B 99 NZ REMARK 470 GLU B 103 CG CD OE1 OE2 REMARK 470 LYS B 138 CD CE NZ REMARK 470 ILE B 161 CG1 CG2 CD1 REMARK 470 LYS B 164 CD CE NZ REMARK 470 LYS B 186 CE NZ REMARK 470 GLU B 191 CG CD OE1 OE2 REMARK 470 GLN B 195 CD OE1 NE2 REMARK 470 GLU B 204 CG CD OE1 OE2 REMARK 470 GLU B 206 CD OE1 OE2 REMARK 470 ARG B 233 NE CZ NH1 NH2 REMARK 470 GLU B 242 CD OE1 OE2 REMARK 470 GLU B 248 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 116 CB - CG - CD1 ANGL. DEV. = 5.0 DEGREES REMARK 500 ARG A 122 NE - CZ - NH1 ANGL. DEV. = 5.3 DEGREES REMARK 500 ARG A 122 NE - CZ - NH2 ANGL. DEV. = -4.0 DEGREES REMARK 500 HIS A 133 C - N - CA ANGL. DEV. = 15.1 DEGREES REMARK 500 HIS A 133 CA - CB - CG ANGL. DEV. = 11.3 DEGREES REMARK 500 ARG A 231 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG B 148 NE - CZ - NH1 ANGL. DEV. = 3.7 DEGREES REMARK 500 ARG B 148 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 12 26.86 86.42 REMARK 500 THR A 67 14.13 -141.02 REMARK 500 GLN A 171 -105.90 59.36 REMARK 500 ASP A 185 -112.14 45.75 REMARK 500 CYS A 228 -78.44 -122.92 REMARK 500 ASP B 12 23.10 87.54 REMARK 500 ALA B 55 56.87 -142.78 REMARK 500 GLN B 171 -109.39 60.04 REMARK 500 ASP B 185 -115.05 48.53 REMARK 500 CYS B 228 -78.33 -130.66 REMARK 500 CYS B 228 -78.46 -130.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 359291 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION REMARK 999 TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV REMARK 999 PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET REMARK 999 SEQUENCE. DBREF 2I5I A 1 262 UNP P59745 Y3048_ENTFA 1 262 DBREF 2I5I B 1 262 UNP P59745 Y3048_ENTFA 1 262 SEQADV 2I5I GLY A 0 UNP P59745 LEADER SEQUENCE SEQADV 2I5I MSE A 1 UNP P59745 MET 1 MODIFIED RESIDUE SEQADV 2I5I MSE A 48 UNP P59745 MET 48 MODIFIED RESIDUE SEQADV 2I5I MSE A 79 UNP P59745 MET 79 MODIFIED RESIDUE SEQADV 2I5I MSE A 117 UNP P59745 MET 117 MODIFIED RESIDUE SEQADV 2I5I MSE A 179 UNP P59745 MET 179 MODIFIED RESIDUE SEQADV 2I5I MSE A 199 UNP P59745 MET 199 MODIFIED RESIDUE SEQADV 2I5I MSE A 229 UNP P59745 MET 229 MODIFIED RESIDUE SEQADV 2I5I MSE A 262 UNP P59745 MET 262 MODIFIED RESIDUE SEQADV 2I5I GLY B 0 UNP P59745 LEADER SEQUENCE SEQADV 2I5I MSE B 1 UNP P59745 MET 1 MODIFIED RESIDUE SEQADV 2I5I MSE B 48 UNP P59745 MET 48 MODIFIED RESIDUE SEQADV 2I5I MSE B 79 UNP P59745 MET 79 MODIFIED RESIDUE SEQADV 2I5I MSE B 117 UNP P59745 MET 117 MODIFIED RESIDUE SEQADV 2I5I MSE B 179 UNP P59745 MET 179 MODIFIED RESIDUE SEQADV 2I5I MSE B 199 UNP P59745 MET 199 MODIFIED RESIDUE SEQADV 2I5I MSE B 229 UNP P59745 MET 229 MODIFIED RESIDUE SEQADV 2I5I MSE B 262 UNP P59745 MET 262 MODIFIED RESIDUE SEQRES 1 A 263 GLY MSE SER ASN LYS LYS LEU ILE ILE ASN ALA ASP ASP SEQRES 2 A 263 PHE GLY TYR THR PRO ALA VAL THR GLN GLY ILE ILE GLU SEQRES 3 A 263 ALA HIS LYS ARG GLY VAL VAL THR SER THR THR ALA LEU SEQRES 4 A 263 PRO THR SER PRO TYR PHE LEU GLU ALA MSE GLU SER ALA SEQRES 5 A 263 ARG ILE SER ALA PRO THR LEU ALA ILE GLY VAL HIS LEU SEQRES 6 A 263 THR LEU THR LEU ASN GLN ALA LYS PRO ILE LEU PRO ARG SEQRES 7 A 263 GLU MSE VAL PRO SER LEU VAL ASP GLU ALA GLY TYR PHE SEQRES 8 A 263 TRP HIS GLN SER ILE PHE GLU GLU LYS VAL ASN LEU GLU SEQRES 9 A 263 GLU VAL TYR ASN GLU TRP ASP ALA GLN ILE ILE SER PHE SEQRES 10 A 263 MSE LYS SER GLY ARG ARG PRO ASP HIS ILE ASP SER HIS SEQRES 11 A 263 HIS ASN VAL HIS GLY LYS ASN LYS LYS LEU LEU GLY VAL SEQRES 12 A 263 ALA LEU ALA LEU ALA ARG LYS TYR GLN LEU PRO LEU ARG SEQRES 13 A 263 ASN ALA SER ARG SER ILE GLU THR LYS ASP TYR LEU GLU SEQRES 14 A 263 LEU TYR GLN ASP VAL ARG THR PRO ASP GLU MSE LEU TYR SEQRES 15 A 263 GLN PHE TYR ASP LYS ALA ILE SER THR GLU THR ILE LEU SEQRES 16 A 263 GLN LEU LEU ASP MSE VAL VAL CYS SER GLU GLY GLU VAL SEQRES 17 A 263 PHE GLU ILE ASN CYS HIS PRO ALA PHE ILE ASP THR ILE SEQRES 18 A 263 LEU GLN ASN GLN SER GLY TYR CYS MSE PRO ARG ILE ARG SEQRES 19 A 263 GLU VAL GLU ILE LEU THR SER GLN GLU VAL LYS GLU ALA SEQRES 20 A 263 ILE GLU GLU ARG GLY ILE LEU LEU ALA ASN TYR GLU SER SEQRES 21 A 263 LEU ALA MSE SEQRES 1 B 263 GLY MSE SER ASN LYS LYS LEU ILE ILE ASN ALA ASP ASP SEQRES 2 B 263 PHE GLY TYR THR PRO ALA VAL THR GLN GLY ILE ILE GLU SEQRES 3 B 263 ALA HIS LYS ARG GLY VAL VAL THR SER THR THR ALA LEU SEQRES 4 B 263 PRO THR SER PRO TYR PHE LEU GLU ALA MSE GLU SER ALA SEQRES 5 B 263 ARG ILE SER ALA PRO THR LEU ALA ILE GLY VAL HIS LEU SEQRES 6 B 263 THR LEU THR LEU ASN GLN ALA LYS PRO ILE LEU PRO ARG SEQRES 7 B 263 GLU MSE VAL PRO SER LEU VAL ASP GLU ALA GLY TYR PHE SEQRES 8 B 263 TRP HIS GLN SER ILE PHE GLU GLU LYS VAL ASN LEU GLU SEQRES 9 B 263 GLU VAL TYR ASN GLU TRP ASP ALA GLN ILE ILE SER PHE SEQRES 10 B 263 MSE LYS SER GLY ARG ARG PRO ASP HIS ILE ASP SER HIS SEQRES 11 B 263 HIS ASN VAL HIS GLY LYS ASN LYS LYS LEU LEU GLY VAL SEQRES 12 B 263 ALA LEU ALA LEU ALA ARG LYS TYR GLN LEU PRO LEU ARG SEQRES 13 B 263 ASN ALA SER ARG SER ILE GLU THR LYS ASP TYR LEU GLU SEQRES 14 B 263 LEU TYR GLN ASP VAL ARG THR PRO ASP GLU MSE LEU TYR SEQRES 15 B 263 GLN PHE TYR ASP LYS ALA ILE SER THR GLU THR ILE LEU SEQRES 16 B 263 GLN LEU LEU ASP MSE VAL VAL CYS SER GLU GLY GLU VAL SEQRES 17 B 263 PHE GLU ILE ASN CYS HIS PRO ALA PHE ILE ASP THR ILE SEQRES 18 B 263 LEU GLN ASN GLN SER GLY TYR CYS MSE PRO ARG ILE ARG SEQRES 19 B 263 GLU VAL GLU ILE LEU THR SER GLN GLU VAL LYS GLU ALA SEQRES 20 B 263 ILE GLU GLU ARG GLY ILE LEU LEU ALA ASN TYR GLU SER SEQRES 21 B 263 LEU ALA MSE MODRES 2I5I MSE A 48 MET SELENOMETHIONINE MODRES 2I5I MSE A 79 MET SELENOMETHIONINE MODRES 2I5I MSE A 117 MET SELENOMETHIONINE MODRES 2I5I MSE A 179 MET SELENOMETHIONINE MODRES 2I5I MSE A 199 MET SELENOMETHIONINE MODRES 2I5I MSE A 229 MET SELENOMETHIONINE MODRES 2I5I MSE A 262 MET SELENOMETHIONINE MODRES 2I5I MSE B 48 MET SELENOMETHIONINE MODRES 2I5I MSE B 79 MET SELENOMETHIONINE MODRES 2I5I MSE B 117 MET SELENOMETHIONINE MODRES 2I5I MSE B 179 MET SELENOMETHIONINE MODRES 2I5I MSE B 199 MET SELENOMETHIONINE MODRES 2I5I MSE B 229 MET SELENOMETHIONINE MODRES 2I5I MSE B 262 MET SELENOMETHIONINE HET MSE A 48 8 HET MSE A 79 8 HET MSE A 117 8 HET MSE A 179 8 HET MSE A 199 8 HET MSE A 229 8 HET MSE A 262 9 HET MSE B 48 8 HET MSE B 79 8 HET MSE B 117 8 HET MSE B 179 8 HET MSE B 199 8 HET MSE B 229 16 HET MSE B 262 9 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 14(C5 H11 N O2 SE) FORMUL 3 HOH *363(H2 O) HELIX 1 1 THR A 16 ARG A 29 1 14 HELIX 2 2 TYR A 43 ALA A 55 1 13 HELIX 3 3 VAL A 80 VAL A 84 5 5 HELIX 4 4 HIS A 92 GLU A 97 1 6 HELIX 5 5 ASN A 101 MSE A 117 1 17 HELIX 6 6 LYS A 118 GLY A 120 5 3 HELIX 7 7 HIS A 130 LYS A 135 5 6 HELIX 8 8 ASN A 136 GLN A 151 1 16 HELIX 9 9 SER A 160 TYR A 170 5 11 HELIX 10 10 TYR A 184 ILE A 188 5 5 HELIX 11 11 SER A 189 SER A 203 1 15 HELIX 12 12 ASP A 218 SER A 225 1 8 HELIX 13 13 MSE A 229 THR A 239 1 11 HELIX 14 14 SER A 240 ARG A 250 1 11 HELIX 15 15 ASN A 256 ALA A 261 5 6 HELIX 16 16 THR B 16 ARG B 29 1 14 HELIX 17 17 TYR B 43 ALA B 55 1 13 HELIX 18 18 VAL B 80 VAL B 84 5 5 HELIX 19 19 ILE B 95 LYS B 99 5 5 HELIX 20 20 ASN B 101 MSE B 117 1 17 HELIX 21 21 LYS B 118 GLY B 120 5 3 HELIX 22 22 HIS B 130 LYS B 135 5 6 HELIX 23 23 ASN B 136 GLN B 151 1 16 HELIX 24 24 SER B 160 TYR B 170 5 11 HELIX 25 25 TYR B 184 ILE B 188 5 5 HELIX 26 26 SER B 189 SER B 203 1 15 HELIX 27 27 ASP B 218 SER B 225 1 8 HELIX 28 28 MSE B 229 SER B 240 1 12 HELIX 29 29 SER B 240 ARG B 250 1 11 HELIX 30 30 ASN B 256 ALA B 261 5 6 SHEET 1 A 6 ILE A 126 SER A 128 0 SHEET 2 A 6 ALA A 59 LEU A 64 1 N LEU A 64 O ASP A 127 SHEET 3 A 6 SER A 34 ALA A 37 1 N ALA A 37 O HIS A 63 SHEET 4 A 6 LYS A 5 PHE A 13 1 N ALA A 10 O SER A 34 SHEET 5 A 6 VAL A 207 CYS A 212 1 O PHE A 208 N LYS A 5 SHEET 6 A 6 GLU A 178 LEU A 180 1 N LEU A 180 O GLU A 209 SHEET 1 B 5 ILE A 126 SER A 128 0 SHEET 2 B 5 ALA A 59 LEU A 64 1 N LEU A 64 O ASP A 127 SHEET 3 B 5 SER A 34 ALA A 37 1 N ALA A 37 O HIS A 63 SHEET 4 B 5 LYS A 5 PHE A 13 1 N ALA A 10 O SER A 34 SHEET 5 B 5 LEU A 253 ALA A 255 1 O LEU A 253 N LEU A 6 SHEET 1 C 6 ILE B 126 SER B 128 0 SHEET 2 C 6 ALA B 59 LEU B 64 1 N LEU B 64 O ASP B 127 SHEET 3 C 6 SER B 34 ALA B 37 1 N ALA B 37 O HIS B 63 SHEET 4 C 6 LYS B 4 PHE B 13 1 N ALA B 10 O SER B 34 SHEET 5 C 6 VAL B 207 CYS B 212 1 O ILE B 210 N ILE B 7 SHEET 6 C 6 GLU B 178 LEU B 180 1 N LEU B 180 O GLU B 209 SHEET 1 D 5 ILE B 126 SER B 128 0 SHEET 2 D 5 ALA B 59 LEU B 64 1 N LEU B 64 O ASP B 127 SHEET 3 D 5 SER B 34 ALA B 37 1 N ALA B 37 O HIS B 63 SHEET 4 D 5 LYS B 4 PHE B 13 1 N ALA B 10 O SER B 34 SHEET 5 D 5 ILE B 252 ALA B 255 1 O LEU B 253 N LEU B 6 LINK C ALA A 47 N MSE A 48 1555 1555 1.34 LINK C MSE A 48 N GLU A 49 1555 1555 1.34 LINK C GLU A 78 N MSE A 79 1555 1555 1.33 LINK C MSE A 79 N VAL A 80 1555 1555 1.33 LINK C PHE A 116 N MSE A 117 1555 1555 1.33 LINK C MSE A 117 N LYS A 118 1555 1555 1.32 LINK C GLU A 178 N MSE A 179 1555 1555 1.32 LINK C MSE A 179 N LEU A 180 1555 1555 1.33 LINK C ASP A 198 N MSE A 199 1555 1555 1.33 LINK C MSE A 199 N VAL A 200 1555 1555 1.34 LINK C CYS A 228 N MSE A 229 1555 1555 1.34 LINK C MSE A 229 N PRO A 230 1555 1555 1.32 LINK C ALA A 261 N MSE A 262 1555 1555 1.31 LINK C ALA B 47 N MSE B 48 1555 1555 1.34 LINK C MSE B 48 N GLU B 49 1555 1555 1.34 LINK C GLU B 78 N MSE B 79 1555 1555 1.34 LINK C MSE B 79 N VAL B 80 1555 1555 1.34 LINK C PHE B 116 N MSE B 117 1555 1555 1.33 LINK C MSE B 117 N LYS B 118 1555 1555 1.33 LINK C GLU B 178 N MSE B 179 1555 1555 1.33 LINK C MSE B 179 N LEU B 180 1555 1555 1.33 LINK C ASP B 198 N MSE B 199 1555 1555 1.33 LINK C MSE B 199 N VAL B 200 1555 1555 1.33 LINK C CYS B 228 N BMSE B 229 1555 1555 1.34 LINK C CYS B 228 N AMSE B 229 1555 1555 1.33 LINK C BMSE B 229 N PRO B 230 1555 1555 1.33 LINK C AMSE B 229 N PRO B 230 1555 1555 1.33 LINK C ALA B 261 N MSE B 262 1555 1555 1.30 CRYST1 130.530 130.530 85.760 90.00 90.00 120.00 H 3 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007660 0.004420 0.000000 0.00000 SCALE2 0.000000 0.008850 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011660 0.00000 MASTER 343 0 14 30 22 0 0 6 0 0 0 42 END